Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Colorectal

Explore clinical trials studying Neoplasms, Colorectal. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Colorectal trial results

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Completed

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

NCT03428958

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

NCT00967616

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • St. Jude Heritage Medical Group Fullerton, California, United States
  • John Marshall Washington D.C., District of Columbia, United States
  • Georgia Cancer Specialists Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Completed

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

NCT00387387

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • GSK Investigational Site Hyderabad, Andhra Pradesh, India
  • GSK Investigational Site Pārel, India
  • GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom
  • GSK Investigational Site Oxford, Oxfordshire, United Kingdom
View Trial Details

Related conditions